Ashish Ranjan to Adjuvants, Immunologic
                            
                            
                                This is a "connection" page, showing publications Ashish Ranjan has written about Adjuvants, Immunologic.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.640
         
        
        
     
 
    
        
        - 
            Cancer immunotherapy with immunoadjuvants, nanoparticles, and checkpoint inhibitors: Recent progress and challenges in treatment and tracking response to immunotherapy. Pharmacol Ther. 2020 03; 207:107456.
            
            
                Score: 0.640